The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic effects of TP53 variants co-occuring in patients with HER2-mutated non-small cell lung cancer (NSCLC).
 
Jamie Feng
Honoraria - AstraZeneca Canada
 
Katrina Hueniken
No Relationships to Disclose
 
Zhen (Jason) Fan
No Relationships to Disclose
 
Lucy Corke
No Relationships to Disclose
 
Natasha B. Leighl
Research Funding - Amgen (Inst); AstraZeneca Canada (Inst); Bayer (Inst); EMD Serono (Inst); Guardant Health (Inst); Lilly (Inst); MSD (Inst); MSD Oncology (Inst); Roche Canada (Inst); Roche Canada (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Merck Sharp & Dohme
 
Geoffrey Liu
Honoraria - Abbvie; Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Jazz Pharmaceuticals; Merck; novartis; pfizer; Roche Canada; Takeda
Consulting or Advisory Role - AstraZeneca/MedImmune; novartis; pfizer; Roche Canada; takeda
Speakers' Bureau - AstraZeneca; Pfizer; Takeda
Research Funding - AstraZeneca/MedImmune (Inst); Boehringer Ingelheim; roche (Inst); Takeda
 
Penelope Ann Bradbury
Consulting or Advisory Role - Mirati Therapeutics
(OPTIONAL) Uncompensated Relationships - Abbvie; Bristol-Myers Squibb
 
Adrian G. Sacher
Research Funding - AstraZeneca; BMS; Genentech/Roche
(OPTIONAL) Uncompensated Relationships - AstraZeneca; Genentech/Roche
 
Lawson Eng
No Relationships to Disclose
 
Tracy Stockley
Consulting or Advisory Role - Bayer; Janssen; Pfizer
 
Ming Sound Tsao
Honoraria - Sanofi/Regeneron
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; Daiichi Sankyo/Astra Zeneca; Lilly
Speakers' Bureau - Abbvie; Sanofi
Research Funding - AstraZeneca/MedImmune (Inst); Bayer (Inst); Sanofi (Inst)
 
Frances A. Shepherd
Stock and Other Ownership Interests - AstraZeneca; Lilly
Honoraria - AstraZeneca; Daiichi Sankyo; Merck Serono; Takeda
Consulting or Advisory Role - AstraZeneca; Merck Serono
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Pfizer (Inst); Roche Canada (Inst)